GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » 12-1 Month Momentum %

CSPC Pharmaceutical Group (HKSE:01093) 12-1 Month Momentum % : -19.52% (As of Apr. 29, 2024)


View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-29), CSPC Pharmaceutical Group's 12-1 Month Momentum % is -19.52%.

The industry rank for CSPC Pharmaceutical Group's 12-1 Month Momentum % or its related term are showing as below:

HKSE:01093's 12-1 Month Momentum % is ranked worse than
67.41% of 1114 companies
in the Drug Manufacturers industry
Industry Median: -5.73 vs HKSE:01093: -19.52

Competitive Comparison of CSPC Pharmaceutical Group's 12-1 Month Momentum %

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's 12-1 Month Momentum % falls into.



CSPC Pharmaceutical Group  (HKSE:01093) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CSPC Pharmaceutical Group  (HKSE:01093) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


CSPC Pharmaceutical Group 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (HKSE:01093) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines